Author

A. Greene

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Ecology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:database / resource· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:ecology & biodiversity· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Portnoff· 1 shared A. Schlaff· 1 shared B. Zhou· 1 shared C. Dillen· 1 shared C. M. Eakin· 1 shared C. S. Couch· 1 shared D. Fenner· 1 shared D. Manzello· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Portnoff

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multi-Factor Coral Disease Risk Forecasting for Early Warning and Management

J. M. Caldwell, G. Liu, E. Geiger, S. F. Heron, C. M. Eakin, J. De La Cour, A. Greene, L. Raymundo, J. Dryden, A. Schlaff, J. S. Stella, T. L. Kindinger, C. S. Couch, D. Fenner, W. Hoot, , M. J. Donahue

This paper develops a coral disease risk forecasting system using ecological and environmental data to predict disease risk in coral reefs, showing improved accuracy compared to previous systems.

bioRxiv · Oct 23, 2023 · PreprintEcology

Immunogenicity and In vivo protection of a variant nanoparticle vaccine that confers broad protection against emerging SARS-CoV-2 variants

J. Logue, R. Johnson, N. Patel, B. Zhou, S. Maciejewski, H. Zhou, A. Portnoff, J.-H. Tian, M. McGrath, R. Haupt, S. Weston, H. Hammod, M. Guebre-Xabier, C. Dillen, J. Plested, , M. Frieman

This study evaluates a nanoparticle vaccine against SARS-CoV-2 variants, showing it induces strong immune responses and protection in mice and baboons against multiple variants.

bioRxiv · Jun 8, 2021 · PreprintImmunology